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Overview of the Meetings
In this report we will discuss implications for
researchers of variability in estrogenic activity
in animal feed and provide examples of a
number of end points that are sensitive to
estrogenic components in rodent diets.
Importantly, we will report how research is
impacted by variability in estrogenic compo-
nents in soy-based and casein-based diets. We
also describe control procedures to address
the issue of batch-to-batch variability in ani-
mal diets. A primary concern expressed dur-
ing these two workshops sponsored by the
National Institutes of Health (NIH) was a
need to increase awareness within the scien-
tiﬁc and laboratory animal medicine commu-
nity about the variability in estrogenic activity
in diets associated with different components
used in diets and the potential impact on a
wide range of end points. 
The primary objective of the first work-
shop was to review the literature to assess
whether dietary estrogens could signiﬁcantly
affect hormonal and other end points in exper-
imental animals. Based on the consensus that
there were signiﬁcant effects, a second work-
shop was held to develop strategies to reduce
the problems caused by batch-to-batch varia-
tion in estrogenic compounds in animal diets.
Meeting participants agreed that it was critical
to inform scientists, laboratory animal medi-
cine personnel, animal caretakers, scientific
societies, and funding agencies about these
issues. Participants also developed a plan that
provides a solution for conﬁrming the level of
estrogenic activity in each diet in order to
address the problem of undefined batch-to-
batch variability in estrogenic activity in diets. 
The following critical issues were dis-
cussed at the two workshops: 
• Even though the protein content of soy-
containing animal diets is constant, the
phytoestrogen content can vary 2- to 5-fold
between different batches of the same com-
mercial rodent diet. Other estrogenic conta-
minants also vary from batch to batch.
• Phytoestrogens in soy-based animal diets are
biologically active and affect experimental
results, including masking the effect of posi-
tive control estrogens. There are species and
strain differences in the response to varia-
tion in dietary phytoestrogens.
• Research ﬁndings support the need for labo-
ratory animal diet manufacturers/vendors to
confirm content and activity of estrogenic
compounds in at least some of their rodent
diets and make this information available to
investigators. These assays should ideally be
done on a batch-to-batch basis for both soy-
containing and for soy-free diets so that
researchers will be able to use batches with
similar estrogenic content. 
• These findings also emphasize the impor-
tance of the diet in rodent studies, because
uncontrolled variability in estrogenic activ-
ity in feed can interfere with replication of
results within and between laboratories.
There is thus a need to educate investigators
about these issues.
Findings presented at the workshops pro-
vided evidence that some batches of diets with
no measurable isoﬂavones (and thus assumed
by many scientists to be estrogen-free) con-
tained other substances with estrogenic activ-
ity, such as zearalenone, a nonsteroidal
estrogen produced by mold (Katzenellenbogen
et al. 1979), and other unidentiﬁed estrogenic
compounds. These ﬁndings provide a rationale
for the recommendation to use bioassays to
complement chemical analysis in assessing the
total estrogenic activity of rodent diets. 
Types of Feed and Sources of
Variability in Estrogenic Activity
in Commercial Animal Feed
Types of laboratory animal diets. Three major
types of commercial diets produced for labo-
ratory rodents were discussed at the work-
shops: a) natural ingredient diets, which are
formulated with agricultural products and by-
products such as whole grains (e.g., ground
wheat, ground corn, ground oats), mill by-
products (e.g., wheat bran, wheat middlings,
corn gluten meal), and high-protein meals
(e.g., soybean meal, alfalfa meal, fishmeal),
and contain added mineral and vitamins;
b) puriﬁed rodent diets, which are formulated
with reﬁned ingredients such as casein or soy
protein isolate, sugar, starch, vegetable oil,
and cellulose (Reeves 1997); and c) chemi-
cally defined diets, which are formulated
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were held to a) assess whether dietary estrogens could signiﬁcantly impact end points in experimen-
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associated with measuring and eliminating batch-to-batch variability in rodent diets that may lead
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[Online 5 December 2007]using chemically pure compounds such as
amino acids, sugars, triglycerides, fatty acids,
and inorganic salts (Knapka 1985). All nat-
ural ingredient laboratory animal diets can be
classiﬁed as being either open- or closed-for-
mula diets. For open-formula diets, the quan-
titative ingredients are published and open to
the public. In contrast, for closed formula
diets, only the ingredients are listed, but the
precise concentration of components is
unknown or proprietary. 
Impact on phenotype of phytoestrogen
levels in soy-containing diets. Various plant
species naturally produce hormonally active
compounds. These include, but are not lim-
ited to, the isoﬂavones from soy, coumestrol (a
coumestan found in alfalfa), lignans from
ﬂaxseed, and some fungal mycotoxins, such as
zearalenone, that contaminate plant products.
However, the primary known source of active
estrogenic chemicals present in most rodent
diets is isoﬂavones. The two main isoﬂavone
conjugates, genistin and daidzin, are not estro-
genic, but they are hydrolyzed in the intestinal
tract to form the aglycones, genistein and
daidzein, which have estrogenic activity
(Setchell et al. 2002). In addition, equol, a
metabolite of daidzein, is formed by bacteria
in all rodents fed soy-containing diets and in
some humans consuming soy foods (Setchell
and Cole 2006). Equol has estrogenic activity
and is also an antiandrogen that antagonizes
the actions of dihydrotestosterone in vitro
(Lund et al. 2004).
A survey of available diets revealed that
most of the commonly used commercial
rodent diets are formulated with significant
levels of soy protein, and plasma and urinary
isoflavone concentrations correlate well with
dietary isoflavone intake in mice and rats
(Brown and Setchell 2001; Thigpen et al.
2003), similar to findings from humans and
other animals (Setchell et al. 1987a, 1997).
Setchell and Cole (2003) described a high vari-
ability in the isoﬂavone content of puriﬁed soy
protein isolates and soy foods sold to humans,
highlighting the difﬁculty that manufacturers
of the raw ingredients have in controlling for
isoflavone levels in soy-protein products. A
large variability in isoﬂavone content is found
in different species of soybeans; this is caused
by genetic and environmental factors, use of
pesticides, and also changes occurring with
processing and storage (Hoeck et al. 2000;
Hou and Chang 2002; Tsukamoto et al.
1995). Natural ﬂuctuations in sources of soy
protein will result in batch-to-batch variation
in total isoﬂavone content of the diet, even if
the concentration of soy protein is kept con-
stant. Thus, variability in estrogenicity of soy-
based diets is to be expected. There was
consensus at the workshops that laboratory diet
manufacturers basically have no means to con-
trol the level of isoﬂavones without varying the
soy protein content of the diet. Because of the
difﬁculty in maintaining a constant soy-protein
content, rodent diets will vary dramatically in
estrogenic potency from batch to batch and
among different manufacturer’s diets. 
Both endogenous and exogenous estrogens
have a very wide range of effects in both males
and females. These effects are mediated by
both the classical nuclear estrogen receptors
(ER-α and ER-β), which are ligand-activated
transcription factors, and the more recently
discovered ERs associated with the cell mem-
brane, which act via second-messenger systems
to cause rapid changes in cell function
(reviewed by Welshons et al. 2006). The soy
isoﬂavone genistein and equol, the major circu-
lating isoﬂavone metabolites in rodents fed soy
diets, have higher afﬁnity for the nuclear ER-β
than the classical ER-α. These are then, by
deﬁnition, selective ER modulators (SERMs).
At the workshops, numerous examples
were presented showing the relationship
between levels of isoflavones in feed and a
variety of traits in rats and mice, such as the
timing of opening of the vaginal canal, an
estrogen-sensitive biomarker of sexual
maturation in mice (Thigpen et al. 2003,
2004b); the timing of embryo implantation
in rats (Wang et al. 2005); and the incidence
and timing of onset of spontaneous vulvar
carcinomas in mice (Thigpen et al. 2001).
Thigpen et al. (2004b) suggested that diets
essentially lacking in known sources of phyto-
estrogens should be fed to females when they
are being examined after weaning and before
puberty, when endogenous levels of estradiol
are very low. 
In contrast, other workshop participants
suggested that the use of soy-free diets could be
problematic, depending on the life stage,
experimental design, animal model, and end
points assessed. For example, a paradoxical
ﬁnding is that the absence of estrogenic activity
in the feed during pregnancy resulted in the
“fetal estrogenization syndrome” and obesity
during later adulthood in CD-1 mice (Ruhlen
et al. 2008). Additional research has shown
marked differences in metabolism in CD-1
mice fed estrogen-free diets compared with
those fed diets containing phytoestrogens
beginning at conception, with the absence of
soy isoﬂavones resulting in an increase in body
weight, a decrease in glucose tolerance,
decreased metabolic rate and activity level, and
other metabolic changes associated with obe-
sity (Cederroth et al. 2007). These findings
illustrate the potential for a wide range of
impacts on phenotype of eliminating phyto-
estrogens and other estrogenic contaminants
commonly found in commercial diets.
Investigators need to pay particular attention
to the potential effect of diet on all end points,
not just end points such as vaginal opening
that are used as common bioassays for estrogen
exposure (Cooke and Naaz 2004; Jensen and
Ritskes-Hoitinga 2007).
Strain differences in the response to
isoﬂavones in feed. Signiﬁcant differences have
been found in the responsiveness of different
species and strains of animals to dietary phyto-
estrogens (Thigpen et al. 2004a). For example,
the CD-1 mouse and F344 rat are both
extremely sensitive to variation in the levels of
isoﬂavones in phytoestrogen-containing diets,
whereas the Sprague-Dawley rat is signifi-
cantly less sensitive, as measured by the effect
of different diets on the timing of vaginal
opening (Thigpen et al. 2007). This ﬁnding is
consistent with several reports showing the
Sprague-Dawley rat to be less responsive than
the F344 rat to other xenoestrogens (vom Saal
and Hughes 2005). 
Life stage. Workshop participants noted
that it is critical to consider life stage when
examining the effect of phytoestrogens on
phenotype. It is uncommon for commercial
vendors of laboratory animals to inform inves-
tigators or laboratory animal care personnel of
the specific diet(s) used during breeding
and/or maintenance of animals before delivery
to the research facility. Such information is
highly relevant because, during critical periods
in development, components of the diet can
result in programming of genes, resulting in
gene silencing or gene activation (Anway and
Skinner 2006; Dolinoy et al. 2007).
Batch-to-Batch Variability 
in Estrogenic Activity in 
Soy-Containing Diets
Central to the focus of these workshops was
the issue of variability in research results asso-
ciated with batch-to-batch variability in the
phytoestrogen content of rodent diets that
contain soy protein. The ratio of soy iso-
flavones to total protein in purified soy-pro-
tein isolates used as raw material to formulate
soy food can vary by 3- to 5-fold; this vari-
ability is exclusively due to the variability in
isoﬂavone content, because total protein con-
tent generally shows little (~ 3%) variation
(Setchell and Cole, 2003; Thigpen et al.
1999, 2003). This variability is exacerbated
when the amount of soy-protein ingredients
also varies from batch to batch, as is the case
in closed-formula diets that are changed to
maintain constant nutrition.
In several studies of prepubertal female
rats and mice, a failure to reproduce uterine
weight changes and timing of vaginal opening
was shown to be the result of batch-to-batch
variability in the phytoestrogen content of the
diet. This disruption of research due to batch-
to-batch variability in feed occurred in differ-
ent experiments that involved diets purchased
from two different feed manufacturers, indi-
cating that this is not a problem associated
with any speciﬁc manufacturer, but is, instead,
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soy (Boettger-Tong et al. 1998; Thigpen et al.
2003, 2004a, 2004b). For example, Thigpen
et al. (2003) reported that a batch of Purina
5002 diet containing a high background level
of phytoestrogens disrupted the ability to use
the vaginal opening bioassay to detect the
well-characterized puberty-accelerating action
of the potent synthetic estrogen diethylstilbe-
strol (DES), whereas DES effects were
observed with another batch of Purina 5002
that had much lower phytoestrogen levels. 
Controlling versus Eliminating
Batch-to-Batch Variation 
in Estrogenic Activity in 
Animal Diets
The most logical and practical approach for
eliminating variability of estrogenic activity in
rodent diets would be to eliminate dietary
ingredients that contain known estrogenic
compounds (Thigpen et al. 1998, 1999,
2004b). Many researchers have used soy-free
diets and suggested that these diets should be
used for studies of estrogenic chemicals
(Casanova et al. 1999; Kanno et al. 2002;
Stroheker et al. 2003; You et al. 2002). Indeed,
use of non-soy/alfalfa-based diets would permit
a physiology and phenotype to be established
in the absence of phytoestrogens. However,
Thigpen et al. (2004b) cautioned that the diet
selected for any given study should depend on
the speciﬁc objective(s) of the study, and that
the diet selected should reduce study variabil-
ity, not increase study variability. 
The findings presented at the workshop
clearly demonstrated that animals fed
soy/alfalfa-free diets might not be comparable to
historical data generated in animals fed diets
high in phytoestrogens; of particular concern
was that the absence of soy in the feed led to
obesity in CD-1 mice (Cederroth et al. 2007;
Ruhlen et al. 2008). Whether changing the type
of protein in the diet from soy to casein results
in a different but normal phenotype or a differ-
ent but abnormal phenotype is still a question
that will require additional research in different
animal models, but an impact on phenotype
should be expected. The source of the protein
may not be as important as the estrogenic activ-
ity of the diet, including the unique proﬁle of
estrogenic contaminants that contribute to the
total estrogenic activity. The use of soy- or non-
soy–containing diets is an issue that researchers
should carefully consider as part of their experi-
mental design; at the workshops there was agree-
ment that there is no one optimum diet for
conducting all types of research. 
An important consideration regarding the
choice of animal feed is that batch-to-batch
variability in estrogenicity has also been
observed in soy-free rodent diets that contain
casein as a protein source. Researchers should
be aware that a soy-free diet cannot automati-
cally be assumed to be an estrogen-free diet,
because there are many potential sources of
estrogenic contaminants in the various ingre-
dients used in commercial soy-free feeds
(vom Saal et al. 2004). 
Measuring and Controlling
Batch-to-Batch Variability in
Estrogenic Components of
Commercial Rodent Diets
Workshop participants proposed a paradigm
combining two approaches to provide infor-
mation on the batch-to-batch variability in
estrogenic activity in commercial diets: chem-
ical analysis and bioassay.
Chemical analysis for known estrogenic
compounds. For diets that contain compo-
nents such as soy, chemical analysis should be
conducted for speciﬁc chemical classes that are
sources of variability in estrogenic activity.
These include the isoflavones genistein and
daidzein, glycitein, formononetin, and
biochanin A as well as their respective gluco-
side conjugates. This can be accomplished
using techniques described previously by
many groups (Coward et al. 1993; Setchell and
Cole 2003; Setchell et al. 1987b). Because the
isoﬂavone glucosides do not possess estrogenic
activity in vitro unless they are hydrolyzed in
the gastrointestinal tract to release the
bioavailable aglycones (genistein, daidzein,
and glycitein), hydrolysis of the diet should
ideally precede measurement by HPLC, with
ultraviolet, electrochemical, or mass spectrom-
etry detection (Setchell and Cole 2003;
Setchell et al. 1987b). The approach of mea-
suring total isoflavone concentration (as
opposed to attempting to measure the low
proportion that is not glycosylated) greatly
simpliﬁes the method. Commercial methods
are available for the detection of the myco-
toxin zearalenone; if alfalfa is included in the
diet, coumestans can be determined by HPLC
(Cassidy et al. 2000). The advantage of this
analytical approach is that it will absolutely
detect specific estrogenic compounds and
identify their levels. The disadvantage is that it
is a biased assay that will not detect other
components of the diet that may also have
estrogenic activity. 
In vitro screening bioassays for total estro-
genic activity. To complement the chemical
analyses, a combination of two in vitro bio-
assay methods can be used to screen for estro-
genic activity in rodent diets: one bioassay to
determine if there is estrogenic activity in the
diet, and a follow-up bioassay that could
determine the profile of the contaminants.
These assays have the advantage that they are
unbiased and permit the detection of multiple
unknown components that may have estro-
genic activity. 
An example of a bioassay that uses human
MCF-7 breast cancer cells was described by
Welshons et al. (1990). There are other bio-
assays for estrogenic activity (Jefferson et al.
2002; Thigpen et al. 2001), but they should be
evaluated to determine whether they have the
high sensitivity, speciﬁcity, and high-through-
put capability of the MCF-7 cell proliferation
bioassay. Use of such assays would allow a
more expansive assessment of the presence of
potential estrogenic chemicals in the diets. A
drawback of this approach is that these types of
bioassays are unable to establish the identity of
the estrogenic chemicals; nonspeciﬁc interfer-
ences can potentially lead to false positives
unless the results are supported by a chemical
identity of the estrogenic compound. These
assays would also have limited value in detect-
ing conjugated forms of estrogens unless the
diet extracts were subjected to prior hydrolysis.
Nevertheless, this approach could be helpful in
initial screening of diets using high-throughput
techniques and would alert manufacturers to
potential estrogenic activity of speciﬁc batches
of a diet. These assays are also able to identify
compounds with antiestrogenic activity by
administering a stimulating dose of estradiol
and then determining whether the response to
estradiol is reduced.
Diets assumed to have few or no compo-
nents with estrogenic activity have been found
to contain estrogenic contaminants; therefore,
this bioassay approach is needed even if manu-
facturers or researchers assume that the diet is
free of or low in estrogenic activity. Thus,
workshop participants agreed that although
puriﬁed diets and non-soy/alfalfa–containing
diets would not need to be subjected to chem-
ical analysis for compounds that are not com-
ponents of the diet, they should still be tested
for total estrogenic activity by a sensitive
bioassay.
Creating a proﬁle of the estrogenic activity
in feed by HPLC and bioassay. For batches of
feed that test positive in a bioassay screen, it
was proposed that an additional assay should
be applied to create a proﬁle of the estrogenic
substances. This second-tier assay would
potentially facilitate identifying the compo-
nent(s) of the feed that contributed the conta-
minants. The objective is that once the source
of the contaminant(s) is identified, removal
can be addressed. This second-tier bioassay is
referred to as generating a fingerprint of the
extracted estrogenic compounds (for examples,
see Grady et al. 1991; Howdeshell et al. 2003).
The fingerprint would be determined by
extracting the estrogenic compounds, separat-
ing them by HPLC, and adding the fractions
to cultures containing estrogen-responsive
cells, such as MCF-7 cells. This creates a pro-
ﬁle or ﬁngerprint of fractions that stimulates
estrogen-dependent cell proliferation. This
follow-up ﬁngerprint bioassay would only be
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detected in the diet in the first bioassay for
total estrogenic activity. An important advan-
tage of this second-tier bioassay is that it
would provide information as to whether the
total estrogenic activity in different batches of
a diet is due to the same proﬁle of estrogenic
compounds or to a different profile. In the
latter case, there would be concern that spe-
ciﬁc compounds present in one batch but not
another could act as SERMs with unique
effects on phenotype.
Meeting participants agreed that, taken
together, these two bioassays would provide a
method for monitoring total estrogenic activity
in a diet and also provide additional informa-
tion concerning variability in the components
used in preparing different batches of a diet.
One limitation of this approach is that any
estrogenic compound that is conjugated or
activated by in vivo metabolism would not be
detected. Therefore, complementary approaches
using both bioassay and chemical assays for
detecting and measuring estrogenic substances
in diets is advantageous, provided they are
technically feasible and cost-effective.
Conclusions and
Recommendations
Participants of these two workshops concluded
that investigators would beneﬁt from the avail-
ability of commercial animal diets for which
manufacturers have identiﬁed the components
responsible for estrogenic activity and applied
appropriate manufacturing quality control pro-
cedures to assess the variability between batches
of the diets. Documentation of the estrogenic
activity in diets by chemical analysis coupled
with a bioassay to identify potential batch-to-
batch variability in estrogenic composition can
effectively meet this need. 
Specifically, feed manufacturers should
a) make available animal diets for which the
level of estrogenic activity is identiﬁed based
on bioassay and chemical analysis; and
b) make available diets in which the estro-
genic activity falls within specified ranges,
including diets devoid of estrogen activity.
The following research needs were identi-
fied on the basis of data gaps noted at the
meeting:
• What end points are most sensitive or are
insensitive to the effects of dietary phyto-
estrogens and other estrogenic contaminants?
• What nonclassical estrogenic effects occur
because of variability in estrogenic chemicals
in feed?
• What are the most sensitive life stages for
effects of phytoestrogens and other estro-
genic contaminants on end points?
• What is the optimal range of phytoestrogens
and total estrogenic activity in diets with
regard to optimal health and responsiveness
to experimental treatments?
In conjunction with the manufacturer-
based approaches described above, partici-
pants discussed approaches that can be
implemented by the scientiﬁc community, as
well as regulatory agencies that oversee the
conduct of research on drugs and chemicals:
• Details of diet composition, mill dates, and
the estrogenic content should by adequately
documented in publications, which may
require the use of open-formula diets. This
emphasizes the need for standardized assur-
ance methods. 
• Researchers should be aware of implications
of estrogenic activity in the diet, and be
willing to modify the diet as appropriate for
the specific experimental protocol and end
points. 
• Researchers should be aware of species,
strain, and life stage differences in effects of
phytoestrogen content and other estrogenic
chemicals in the diet being used.
• Positive controls should be used in all exper-
iments. Researchers should not rely on his-
torical control data because estrogenic
contaminants in prior batches of animal
diets, even those assumed to be estrogen-
free, are likely to vary from current batches. 
• Samples of diets should be held for future
analysis of potential contaminants.
Most biomedical researchers are generally
unaware of the type of diets used in a central
animal facility, and information about diet is
often lacking in published reports, despite the
importance of the diet, which has been previ-
ously highlighted in the scientific literature
(Brown and Setchell 2001; Jensen and
Ritskes-Hoitinga, 2007; Thigpen et al. 2003,
2004a, 2004b). The workshop participants
felt that it would be helpful for journals to
request a detailed description of diets, mill
dates, and estrogenic activity, including a
description of how estrogenic activity was
measured. Scientiﬁc societies could also facili-
tate awareness of this problem through sym-
posia and workshops at meetings and in
journal articles. In addition, there is concern
about the potential for animal research to be
impacted by variability in other contaminants,
such as methylmercury (Weiss et al. 2005) and
polychlorinated biphenyls (Environmental
Working Group 2003), which have been pro-
posed to relate to the use of contaminated ﬁsh
meal in some diets. Thus, although our focus
has been on controlling variability in estro-
genic compounds in rodent diets, we hope
that other potential sources of uncontrolled
variability in research results associated with
components of the diet will also be addressed
by laboratory animal diet manufacturers as
new ﬁndings are published.
Although the workshops focused on ani-
mal studies, it seems clear that variation in diet
components may also affect clinical trials; also,
that quality of research would be improved if
more emphasis is placed on dietary compo-
nents and how they may alter experimental
results at all levels. Participants felt it may be
worthwhile having a trans-NIH workshop to
further probe this issue and its effects on both
animal and human experimental protocols. 
We are optimistic about the utility and
manufacturing feasibility of the approaches
presented because workshop participants
included investigators undertaking relevant
research, government scientists, and represen-
tatives from animal feed manufacturers.
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